Neurosurgery Watch

Stay up to date with the latest clinical findings in Neurosurgery Watch. Each month, our panel identifies and summarizes key points of selected significant papers from over 50 journals. We emphasize the most significant findings that potentially change clinical management or treatment of neurological diseases.

Please contact us with any suggestions or comments.

John S. Kuo, MD PhD FACS
Austin, Texas
Co-Editor
Robert Starke, MD MSc
Miami, Florida 
Co-Editor
Search Neurosurgery Watch

Long-Term Risk of Rupture of Unruptured Intracranial Aneurysms Is 1.1%

November 1, 2013
By: 
Robert M. Starke, MD MSC
Source: 
American Heart Association

Our understanding of the natural history of unruptured intracranial aneurysms (UIAs) has been limited by studies with short follow-up. Long-term studies are essential for critically evaluating the role of intervention. Juvela and colleagues followed 142 patients with 181 UIA until...

Operator and Site Experience Impacts Outcomes After Angioplasty and Stenting

November 1, 2013
By: 
Michelle J. Smith, MD
Source: 
Journal of NeuroInterventional Surgery

The Stenting and Aggressive Medical Management for the Prevention of Recurrent Ischemic Stroke (SAMMPRIS), a randomized controlled trial comparing angioplasty and stenting versus medical management for intracranial arterial stenosis, was stopped early due a high 30 day stroke or death...

Routine CT Angiography in Acute Stroke Does Not Delay Thrombolytic Therapy

November 1, 2013
By: 
Justin F. Fraser, MD
Source: 
Canadian Journal of Neurological Sciences

With the emphasis on reducing time from ‘last known normal’ to recanalization, acute stroke therapy requires rapid, accurate diagnosis for treatment decision-making. The authors reviewed 850 stroke thrombolysis patients in a single institution, separated into two groups: the earlier protocol...

STiCH 2: Early Surgery Does Not Provide a Clear Advantage in Lobar ICH

November 1, 2013
By: 
Alexander A. Khalessi, MD
Source: 
http://www.sciencedirect.com/science/article/pii/S0140673613609861

STiCH 2 is a multicenter, prospective randomized trial comparing early craniotomy with conservative management of spontaneous lobar intracerebral hematomas within 1 cm of a cortical surface. Among the 601 patients studied, median ICH volume was 36 cc (23-55cc) and 50%...

TU

Does Prior Microsurgery Improve or Worsen Stereotactic Radiosurgery Outcome for Cavernous Sinus Meningiomas?

October 1, 2013
Tumor
By: 
Jonathan Sherman, MD
J. Bradley Elder, MD
Source: 
Neurosurgery

Cavernous sinus meningiomas are increasingly treated with stereotactic radiosurgery alone or combined with surgical resection of tumor external to the cavernous sinus. From the University of Pittsburgh, Kano et al reported one of the largest series of cavernous sinus meningiomas...

Pages